GURUFOCUS.COM » STOCK LIST » Technology » Semiconductors » GemVax & KAEL Co Ltd (XKRX:082270) » Definitions » Price-to-Operating-Cash-Flow

GemVax & KAEL Co (XKRX:082270) Price-to-Operating-Cash-Flow : (As of May. 09, 2025)


View and export this data going back to 2005. Start your Free Trial

What is GemVax & KAEL Co Price-to-Operating-Cash-Flow?

As of today (2025-05-09), GemVax & KAEL Co's share price is ₩36150.00. GemVax & KAEL Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2024 was ₩-717.34. Hence, GemVax & KAEL Co's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for GemVax & KAEL Co's Price-to-Operating-Cash-Flow or its related term are showing as below:

During the past 13 years, GemVax & KAEL Co's highest Price-to-Operating-Cash-Flow Ratio was 13513.51. The lowest was 5.00. And the median was 151.07.

XKRX:082270's Price-to-Operating-Cash-Flow is not ranked *
in the Semiconductors industry.
Industry Median: 17.04
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

GemVax & KAEL Co's Cash Flow from Operations per share for the three months ended in Dec. 2024 was ₩-176.39. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2024 was ₩-717.34.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of GemVax & KAEL Co was -890.00% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -101.90% per year.

During the past 13 years, GemVax & KAEL Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 68.90% per year. The lowest was -123.50% per year. And the median was -31.40% per year.


GemVax & KAEL Co Price-to-Operating-Cash-Flow Historical Data

The historical data trend for GemVax & KAEL Co's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GemVax & KAEL Co Price-to-Operating-Cash-Flow Chart

GemVax & KAEL Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 67.93 - - 146.48 -

GemVax & KAEL Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 146.48 - - - -

Competitive Comparison of GemVax & KAEL Co's Price-to-Operating-Cash-Flow

For the Semiconductor Equipment & Materials subindustry, GemVax & KAEL Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GemVax & KAEL Co's Price-to-Operating-Cash-Flow Distribution in the Semiconductors Industry

For the Semiconductors industry and Technology sector, GemVax & KAEL Co's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where GemVax & KAEL Co's Price-to-Operating-Cash-Flow falls into.


;
;

GemVax & KAEL Co Price-to-Operating-Cash-Flow Calculation

GemVax & KAEL Co's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=36150.00/-717.339
=

GemVax & KAEL Co's Share Price of today is ₩36150.00.
GemVax & KAEL Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-717.34.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

GemVax & KAEL Co Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of GemVax & KAEL Co's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


GemVax & KAEL Co Business Description

Traded in Other Exchanges
N/A
Address
894, Tamnip-Dong, Yuseong-Gu, Daejeon, KOR, 305-510
GemVax & KAEL Co Ltd is primarily engaged in manufacturing and commercializing of coating resin and filters for semiconductors and panel display production. It offers chemical air filter, scrubber resin, and devices for preventing environmental contamination and eliminating harmful gas, for semiconductor and display industry. Its other business operations include research and development of anti-cancer immunotherapeutic and peptide drugs. The company organizes its business operations into three distinct segments: Environmental Pollution Control Business, IT Business, Bio-business. The company's product portfolio consists fundamental products, semiconductor, and display, equipment and system, fire evacuation mask 5aver.

GemVax & KAEL Co Headlines

No Headlines